News Nahdi Medical Company

Equities

4164

SA15HG521213

Market Closed - Saudi Arabian S.E. Other stock markets 08:20:02 2024-05-23 am EDT			5-day change	1st Jan Change
134.8 ^SAR	+0.30%		-0.44%	-1.61%

May. 08	Nahdi Medical Logs Lower Q1 Net Profit; Revenue Rises	MT
Mar. 18	Nahdi Medical Company Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nahdi Medical Logs Lower Q1 Net Profit; Revenue Rises	May. 08	MT
Nahdi Medical Company Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 18	CI
Nahdi Medical Posts Higher FY23 Net Profit, Revenue	Mar. 18	MT
Nahdi Medical Company Approves Cash Dividend Distribution for the Second Half of 2023	Mar. 17	CI
Nahdi Medical Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 10	CI
OptiBiotix says market still "volatile" but partner sales improving	Nov. 01	AN
Saudi Arabia healthcare group Fakeeh Care weighs IPO, appoints HSBC - sources	23-08-27	RE
Nahdi Medical Company Reports Earnings Results for the Second Quarter Ended June 30, 2023	23-08-02	CI
Nahdi Medical Company Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Nahdi Medical Company Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-19	CI
Nahdi Medical Company Reports Earnings Results for the Third Quarter Ended September 30, 2022	22-11-05	CI
Nahdi Medical Company Reports Earnings Results for the Third Quarter Ended September 30, 2022	22-11-05	CI
OptiBiotix Health gets approval to sell products in Saudi Arabia	22-10-24	AN
OptiBiotix Health Plc Announces Exclusive Distributor Nahdi Medical Co Has Received Approval from the Saudi Food and Drug Authority for GoFigure Shakes and Bars Containing Patented Weight Management Aid Slimbiome	22-10-24	CI
Nahdi Medical Company Announces the Establishment of a New Company, Owned by its Subsidiaries	22-09-29	CI
Certain Ordinary Shares of Nahdi Medical Company are subject to a Lock-Up Agreement Ending on 20-SEP-2022.	22-09-19	CI
Nahdi Medical Company(SASE:4164) added to S&P Global BMI Index	22-09-19	CI
Nahdi Medical Company(SASE:4164) added to S&P Pan Arab Composite	22-09-19	CI
Nahdi Medical Company Announces Distribution of Cash Dividend for First Half of 2022, Payable on August 25, 2022	22-08-09	CI
Nahdi Medical Company(SASE:4164) added to FTSE All-World Index	22-03-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Nahdi Medical Company

Equities

4164

SA15HG521213

Summary

Filters